Blood ghrelin, resistin, and adiponectin concentrations during the normal menstrual cycle

Fertility and Sterility

Volumn 92, Issue 4, 2009, Pages 1389-1394

  Dafopoulos, Konstantinos ^a   Sourlas, Dimitrios ^a   Kallitsaris, Athanasios ^a   Pournaras, Spyros ^a   Messinis, Ioannis E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

adiponectin; Ghrelin; normal menstrual cycle; resistin

Indexed keywords

ADIPONECTIN; ESTROGEN; FOLLITROPIN; GHRELIN; LUTEINIZING HORMONE; PROGESTERONE; RESISTIN;

ADULT; ARTICLE; CYTOKINE PRODUCTION; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ADIPONECTIN; ADULT; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GHRELIN; HUMANS; LONGITUDINAL STUDIES; LUTEINIZING HORMONE; MENSTRUAL CYCLE; OSMOLAR CONCENTRATION; PROGESTERONE; RESISTIN; YOUNG ADULT;

EID: 70349467944     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.07.1773     Document Type: Article

References (39)

1. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86 (2001) 4753-4758
2. van der Lely A.J., Tschop M., Heiman M.L., and Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25 (2004) 426-457
3. Ghigo E., Broglio F., Arvat E., Maccario M., Papotti M., and Muccioli G. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) 62 (2005) 1-17
4. Matsubara M., Sakata I., Wada R., Yamazaki M., Inoue K., and Sakai T. Estrogen modulates ghrelin expression in the female rat stomach. Peptides 25 (2004) 289-297
5. Shibata K., Hosoda H., Kojima M., Kamgawa K., Makino Y., Makino I., et al. Regulation of ghrelin secretion during pregnancy and lactation in the rat: possible involvement of the hypothalamus. Peptides 25 (2004) 279-287
6. Gualillo O., Caminos J.E., Kojima M., Kangawa K., Arvat E., Ghigo E., et al. Gender and gonadal influences on ghrelin mRNA levels in rat stomach. Eur J Endocrinol 144 (2001) 687-690
7. Makino Y., Hosoda H., Shibata K., Makino I., Kojima M., Kamgawa K., et al. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension 39 (2002) 781-784
8. Lebenthal Y., Gat-Yablonski G., Shtaif B., Padoa A., Phillip M., and Lazar L. Effect of sex hormone administration on circulating ghrelin levels in peripubertal children. J Clin Endocrinol Metab 91 (2006) 328-331
9. Grinspoon S., Miller K.K., Herzog D.B., Grieco K.A., and Klibanski A. Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition. J Clin Endocrinol Metab 89 (2004) 3988-3993
10. Kellokoski E., Pöykkö S.M., Karjalainen A.H., Ukkola O., Heikkinen J., Kesäniemi Y.A., et al. Estrogen replacement therapy increases plasma ghrelin levels. J Clin Endocrinol Metab 90 (2005) 2954-2963
11. Chu M.C., Cosper P., Nakhuda G.S., and Lobo R.A. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertil Steril 86 (2006) 1669-1675
12. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
13. Hoffstedt J., Arvidsson E., Sjolin E., Wahlen K., and Arner P. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 89 (2004) 1391-1396
14. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
15. Yannakoulia M., Yiannakouris N., Bluher S., Matalas A.L., Zacas D.K., and Mantzoros C.S. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88 (2003) 1730-1736
16. Kleiblova P., Springer D., and Haluzik M. The influence of hormonal changes during menstrual cycle on serum adiponectin concentrations in healthy women. Physiol Res 55 (2006) 661-666
17. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
18. Gui Y., Silha J.V., and Murphy L.J. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res 12 (2004) 1481-1491
19. Nogueiras R., Gallego R., Gualillo O., Caminos J.E., Garcia-Caballero T., Casanueva F.F., et al. Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. FEBS Lett 548 (2003) 21-27
20. Silha J.V., Krsek M., Skrha J.V., Sucharda P., Nyomba B.L., and Murphy L.J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149 (2003) 331-335
21. Nogueiras R., Gualillo O., Caminos J.E., Casanueva F.F., and Diequez C. Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obes Res 11 (2003) 408-414
22. Di Carlo C., Tommaselli G.A., Gargano V., Sammartino A., Bifulco G., Tauchmanova L., et al. Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women. Menopause 14 (2007) 1-7
23. Chu M., Cosper P., Orio F., Carmina E., and Lobo R. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Am J Obstet Gynecol 194 (2006) 100-104
24. Hong S.C., Yoo S.W., Cho G.J., Kim T., Hur J.Y., Park Y.K., et al. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women. Menopause 14 (2007) 835-840
25. Rechberger T., Tomaszewski J., Pieprzowska-Bialek A., Kulik-Rechberger B., and Skorupski P. Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene. Contraception 69 (2004) 477-480
26. Chalvatzas N, Dafopoulos K, Kosmas G, Kallitsaris A, Pournaras S, Messinis IE. Effect of ovarian hormones on serum adiponectin and resistin concentrations. Fertil Steril. Published online March 5, 2008.
27. D'Eon T.M., Souza S.C., Aronovitz M., Martin S., Obin M.S., Fried S.K., et al. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280 (2005) 35983-35991
28. Huang S.W., Seow K.M., Ho L.T., Chien Y., Chung D.Y., Chang C.L., et al. Resistin mRNA levels are downregulated by estrogen in vivo and in vitro. FEBS Lett 579 (2005) 449-454
29. Chen Y.H., Lee M.J., Chang H.H., Hung P.F., and Kao Y.H. 17 beta-estradiol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor, extracellularly regulated kinase, and CCAAT/enhancer binding protein-alpha pathways. Endocrinology 147 (2006) 4496-4504
30. Gavrila A., Chan J.L., Yiannakouris N., Kontogianni M., Miller L.C., Orlova C., et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88 (2003) 4823-4831
31. Jurimae J., and Jurimae T. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am J Physiol Endocrinol Metab 293 (2007) 42-47
32. Tamakoshi K., Yatsuya H., Wada K., Matsushita K., Otsuka R., Yang P.O., et al. The transition to menopause reinforces adiponectin production and its contribution to improvement of insulin-resistant state. Clin Endocrinol (Oxf) 66 (2007) 65-71
33. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51 (2002) 2734-2741
34. Sieminska L., Wojciechowska C., Niedziolka D., Marek B., Kos-Kudla B., Kajdaniuk D., et al. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism 54 (2005) 1610-1614
35. Im J.A., Lee J.W., Lee H.R., and Lee D.C. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy. Maturitas 54 (2006) 65-71
36. Tworoger S., Mantzoros C., and Hankinson S. Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels. Obesity 15 (2007) 2217-2224
37. Laughlin G.A., Barrett-Connor E., and May S. Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study. Clin Endocrinol (Oxf) 65 (2006) 506-513
38. Ibanez L., and de Zegher F. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. J Clin Endocrinol Metab 89 (2004) 1592-1597
39. Sumino H., Takahashi T., Itoh T., Kusaka K., Yamakawa J., Ichikawa S., et al. Plasma adiponectin levels in post-menopausal women receiving hormone replacement therapy. J Int Med Res 32 (2004) 639-645